Press releases
2022-05-13 13:15
Lipum initiates collaboration with Pelago Bioscience
Pelago Bioscience AB is a fast-growing Swedish company, based in Solna, with bioanalytical expertise and services for drug discovery and development. Pelago...
2022-05-05 17:10
Lipum in consortium being granted research funding by KKS
Lipum is member of the consortium together with both industry and academic partners. The project is led by the Cardiovascular Research Centre (CVRC) at...
2022-04-07 09:00
Lipum abstract accepted for EULAR 2022
The aim of Annual European Congress of Rheumatology EULAR 2022 is to provide a forum of the highest standard for scientific (both clinical and basic)...
2022-03-25 06:00
Lipum AB – Year-end report 2021
CEO Einar Pontén comments: “The last quarter of the year was largely characterized by the fact that we completed activities that constitute...
2022-03-09 08:30
Lipum has entered a partnership with QPS Netherlands B.V. for its first clinical trial with SOL-116
Lipum AB and QPS The Netherlands BV are pleased to announce a collaboration on the first-in-human study of SOL-116 with the aim of becoming a new treatment...
2022-02-24 08:45
Lipum’s GMP production of SOL-116 successful
Lipum's biological drug candidate SOL-116 has successfully been manufactured under the regulations that apply to Good Manufacturing Practice (GMP). The...
2022-02-02 13:00
Lipum recruits scientist
Lipum's development work is in an intensive phase and an initial clinical phase 1 study is being prepared. Preclinical studies have previously shown promising...
2021-12-22 13:00
Lipum AB - report from extra general meeting
Decision on the introduction of incentive programs for employees and consultants The meeting resolved that the program shall consist of a maximum of 72,500...
2021-11-26 08:30
Lipum AB - interim report for the period July – September 2021
CEO Einar Pontén comments: “We are progressing according to plan and both toxicology- and safety studies, according to GLP, as well as GMP...
2021-11-22 08:30
Lipum announces the Nomination Committee and that Flerie Invest AB has become a major shareholder
Flerie Invest AB is a reputable investment company with active ownership in biotechnology and pharmaceuticals. The company is controlled by Thomas Eldered...